Register for an account


Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.


Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.


Tobacco Plants Can "Grow" a Vaccine to Fight Lymphoma

80beatsBy Eliza StricklandJuly 22, 2008 6:39 PM


Sign up for our email newsletter for the latest science news

Researchers say they have turned a tobacco plant into a living factory that can produce individualized vaccines to fight a type of cancer known as follicular lymphoma. While similar vaccines have been grown inside animal cells, researchers say this new process is quicker and less expensive, and could carry less risk to the patient, as animal cells might hold unknown viruses

[BBC News].

In the new technique, researchers took biopsies from each lymphoma patient and isolated the gene that produces tumor-fighting antibodies, which is slightly different in each person. In each case, they then used a genetically engineered tobacco virus to bring the gene into a tobacco plant, where the plant responded by turning out antibodies. One week later the tobacco leaves were picked and ground into pulp, and the antibodies were extracted.

These antibodies are put into a patient newly-diagnosed with the disease, to "prime" the body's immune system to attack any cell carrying them. If successful, this would mean the body would then recognise and destroy the lymphoma cells [BBC News].

The study, published in the Proceedings of the National Academy of Sciences [subscription required], suggests that patients who have just been diagnosed with lymphoma could try to fight off the disease without resorting to toxic chemotherapy.

"This would be a way to treat cancer without side effects," [lead researcher Ronald] Levy said in a statement. "The idea is to marshal the body's own immune system to fight cancer" [Reuters].

The study, in 16 newly diagnosed patients, was too small to determine if the vaccine helped, Levy said. It did show the approach is safe and generated the intended immune response [Bloomberg]. Researchers hope to follow up soon with a larger study that could examine the treatment's efficacy in fighting the spread of lymphoma.

Image: flickr/lorentey

2 Free Articles Left

Want it all? Get unlimited access when you subscribe.


Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 70%


Already a subscriber? Register or Log In